VI.b
VI - Cardiomyopathy
Hypertrophic cardiomyopathy
Last update 17/06/2026
Back
The Drug-Induced Respiratory Disease Website
Causative drugs
3
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
VI.b
VI. Cardiomyopathy
VI.b Hypertrophic cardiomyopathy
IX.a
IX. Endocardial involvement
IX.a Endocarditis (infective)
X.b
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
XI.a
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XI.b
XI. Pulmonary vasculopathies
XI.b Acute pulmonary hypertension
XI.e
XI. Pulmonary vasculopathies
XI.e Pulmonary artery aneurysm(s)
XI.i
XI. Pulmonary vasculopathies
XI.i Pulmonary veno-occlusive disease
XIII.h
XIII. Thrombosis - Embolism
XIII.h Mercury pulmonary embolism
XIII.k
XIII. Thrombosis - Embolism
XIII.k Foreign body pulmonary vasculopathy (Excipient lung disease)
XV.a
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXI.c
XXI. Mediastinal involvement/injury
XXI.c Pneumomediastinum
XXI.d
XXI. Mediastinal involvement/injury
XXI.d Mediastinitis
XXVI.c
XXVI. Neuromuscular dysfunction
XXVI.c Acute myelopathy (can cause ARF)
XXX.f
XXX. Imaging features
XXX.f Imaging: Alveolar opacities or haze with a batwing or butterfly distribution
XXXI.e
XXXI. Eye catchers
XXXI.e Eye catcher: A batwing or butterfly pattern on chest imaging
XXXIII.l
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.l Path: Pulmonary hypertension incl. angiomatoid vasculopathy
XXXIII.n
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.n Path: Foreign body embolism, microangiopathy, vasculopathy
XXXIV.a
XXXIV. Infections
XXXIV.a Septic pulmonary embolism
XXXVIII.w
XXXVIII. Miscellaneous - Varia
XXXVIII.w Foreign body (talc, constarch) retinopathy
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
III.b
III. Myocardial ischemia - Coronary artery disease
III.b Coronary artery disease (subacute, chronic)
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VI.b
VI. Cardiomyopathy
VI.b Hypertrophic cardiomyopathy
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
X.a
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XIII.f
XIII. Thrombosis - Embolism
XIII.f Fat/oil embolism - The FES embolism syndrome
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.y
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.y Exogenous lipoid pneumonia (subacute, acute)
XXXVIII.h
XXXVIII. Miscellaneous - Varia
XXXVIII.h Hypoxemia, low oxygen saturation (may occur in isolation)
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
VI.b
VI. Cardiomyopathy
VI.b Hypertrophic cardiomyopathy
XIII.a
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)